Osaka, Japan

Ko Imai


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Osaka, JA (1977)
  • Minoo, JP (1990)

Company Filing History:


Years Active: 1977-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Ko Imai

Introduction

Ko Imai is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of microbiology, particularly in the production of valuable compounds through innovative methods. With a total of 5 patents, Imai's work has garnered attention in both academic and industrial circles.

Latest Patents

Imai's latest patents focus on the production of 2-keto-L-gulonic acid, a compound with various applications. His first patent describes biologically pure cultures of Pseudomonas sorbosoxidans, which are useful for producing 2-keto-L-gulonic acid in high yield by contacting L-sorbose with the microorganism or a processed material thereof. The second patent outlines a method for producing 2-keto-L-gulonic acid, emphasizing the efficiency of using Pseudomonas sorbosoxidans in the process.

Career Highlights

Throughout his career, Ko Imai has worked with prominent companies in the pharmaceutical industry, including Takeda Chemical Industries, Inc. and Takeda Chemical Ind., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in biotechnology.

Collaborations

Imai has collaborated with esteemed colleagues such as Yoshio Kamatani and Hisayoshi Okazaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Ko Imai's contributions to the field of microbiology and his innovative patents highlight his role as a significant inventor. His work continues to influence the production of important compounds, showcasing the impact of his research on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…